Since 2016, we have supported 37 life science startups.
The startups below are currently enrolled in the ProHealth Growth Programme


Adamant Health offers better quality of life for people with Parkinson’s disease and other movement disorders. The novel and innovative technology enables accurate analysis of movement disorders in home environment.


ANISON develops natural compounds and small molecules for targeted treatment of HPV-associated warts and cancers respectively. The team has formulated a plant-based extract as a cream or ointment to be effective in treating all kind of warts including common, plantar and genital warts. Warts are caused by HPV, and the active component in the extract has been shown to be specifically effective against HPV by targeting the underlying cause. The project is in the development phase and a startup is planned to be established in 2020.


Brinter® is the culmination of years of 3D printing expertise and bioresearch. Brinter Oy provides comprehensive 3D bioprinting solutions and services for pharmaceutical, biotechnological and cosmetic industries, universities, and research facilities. Brinter® Bioprinters are always custom-built for clients’ specific applications and needs.




Capsamedix Oy develops devices for long-term oral drug delivery to replace pills, injections, and implants in applications where medication may cause adverse effects or patients have difficulties in remembering to take medication. The technology allows administering drugs locally for oral diseases and through oral mucosa into the systemic circulation for systemic and localized diseases.


Finnadvance Oy develops disease-on-chip for drug discovery and for research. The chips mimic functions of a human organ and allow for more precise and expedient drug discovery. This lowers costs by reducing the need for animal studies. The chips are used to find potential drug candidates for rare diseases and to study efficacy and response. This work will eventually lead to the development of real personalized medicines.


Midifi Oy starts its first business concept thru Estonian and Finnish pharmacies. This service assists the patient in obtaining prescription drugs and / or prescription drugs at the desired time and location.

Midify Oy is developing a completely personal approach to deliver healthcare services to patients everywhere at every time all over Europe. In six words “it’s a fingertip medicine everywhere at every time”.


RoboMed Oy, proposing a wireless capsule robot for endoscopy and real-time biopsy of gastrointestinal tract focusing on the small intestine. A significant application avoiding unwanted surgeries added with the live streaming of procedure via smartphone application.


Electrically assisted RoboRollo™ walker by RoboRollo Oy collects information of the daily movements of elderly people to be used by therapists and physicians for assist their decision-making. The RoboRollo cloud service with AI uses sensor-based health data to build a model for early detection of potential future hazards and possible health issues. RoboRollo helps to maintain muscular fitness by keeping the user active.


StemSight is developing stem cell based therapies to cure blindness. StemSight uses human pluripotent stem cells as a scalable raw material to produce large amounts of therapeutic cells for a rare corneal blindness called limbal stem cell deficiency. This severe form of corneal blindness affects especially young and working age people, who currently suffer without any valid treatment options. StemSight aims to restore vision permanently in these patients using their proprietary technology.”


Visionisti Oy is a privately owned R&D company, specializing in ophthalmic drug delivery. The company is developing and commercialising patented devices for posterior segment suprachoroidal injections.